Expert Opinion on Emerging Drugs (ISSN 1472-8214 [print], 1744-7623 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing structured reviews on Phase II and Phase III drugs/drug classes emerging onto the market across all therapy areas, providing expert opinion on their potential impact on the current management of specific diseases.
Each review article is structured to include:
Concise background to the subject matter
Assessment of medical need for alternative or novel therapies
Assessment of the market and anticipated changes over time
Summary of current research goals
Outline of the scientific rationale for the approach(es) considered<
Analysis of the competitive environment
Discussion of potential development issues
The author’s expert opinion on the potential impact emerging therapies will have on the current management of specific diseases
The audience consists of pharmaceutical and academic scientists, research planners, pharmaceutical product mangers, clinical opinion leaders and healthcare planners.